The ceiling is written in dollars and drawn in shares, and the share count is where the amendment gets interesting. At the $8.70 average issue price the company reported in August [3], the $646.6m already drawn cost roughly 74.3 million shares [1], and the 42,641,847-share Exchange Cap, struck at 19.99% of the count immediately before the amendment [5], implies about 213.3 million shares outstanding at that moment [2]. Multiply that cap by the same $8.70 and you get roughly $371m [3]; add it to the first $1bn of sales, which the cap does not restrict, and about $1.37bn of the $2.5bn headline is reachable at the prices HSI has actually been issuing at, leaving some $1.13bn contingent on a shareholder vote, an exemption, or a share price above $12.02 [4]. The $12.02 is not a floor under the stock [6]; it is the level above which Nasdaq stops counting. Chardan's purchases are conditioned on pricing and volume under the October 2025 agreement [2][13], so even the reachable part arrives in instalments, and as Cointelegraph put it, the $2.5bn is maximum capacity rather than money in hand [14].
The balance sheet is the cleaner half. The fiscal 2026 Form 10-K put total assets near $2.06bn at June 30 with about $1.904bn of it in HYPE [7], which is 92.4% of assets in a single token [10], carried with no debt against a treasury that went from 12.5 million to 29.3 million HYPE over the year [8]. Those 29.3 million tokens at $1.904bn imply a mark near $65 [8] against the $46.77 average cost of the 16.5 million bought in the period [4], about 39% above cost [9]. And $773.4m deployed against $646.6m raised through the facility leaves $126.8m that came from somewhere other than Chardan [11].
The undrawn $1.853bn [5] is what makes this a market-structure item rather than a company item, because the protocol's own engine, on Matt Hougan's August Bitwise numbers, burns roughly $792m of annual revenue into HYPE [11][6], so a fully drawn and deployed facility would amount to something like 2.3 years of protocol buying [7] pre-disclosed to anyone who reads 8-Ks. Or rather, the more interesting version: it is 2.3 years of buying that exists only while HSI's own shares are bid, since the cap binds hardest at low prices and the equity trades as a token proxy, which is what a 30.4% jump in the stock after President Trump's remarks about CFTC chair Michael Selig showed [16] (the company, for its part, says it is independent of the protocol whose token it holds [17]). My view, and I would rather be wrong in public than vague: this is a levered derivative of HYPE, not an independent buyer of it. It reads differently if holders approve issuance under Rule 5635 and the cap stops mattering, if the stock holds above $12.02 so the cap never engages, or if the fee-funded buyback that Coinbase Institutional calls equity-like [10] carries the token unaided, in which case dilution is a question for HSI's shareholders alone. Sustained issuance while HYPE goes sideways would tell me I read it wrong.
